Ammonium Chloride → N-(5-cyano-4-((tetrahydro-2H-pyran-4-yl)oxy)pyridin-2-yl)-7-formyl-6-(hydroxymethyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide

HRID 1778085Notes

Reaction equation

HRID 1778085 reaction equation
[Si]([O:8][CH2:9][C:10]1[CH:11]=[C:12]2[C:17](=[N:18][C:19]=1[CH:20]([O:23]C)OC)[N:16]([C:25]([O:27]C1C=CC=CC=1)=O)[CH2:15][CH2:14][CH2:13]2)(C(C)(C)C)(C)C.[NH2:34][C:35]1[CH:42]=[C:41]([O:43][CH:44]2[CH2:49][CH2:48][O:47][CH2:46][CH2:45]2)[C:38]([C:39]#[N:40])=[CH:37][N:36]=1.[Li+].C[Si]([N-][Si](C)(C)C)(C)C.[NH4+].[Cl-]>C1COCC1>[C:39]([C:38]1[C:41]([O:43][CH:44]2[CH2:49][CH2:48][O:47][CH2:46][CH2:45]2)=[CH:42][C:35]([NH:34][C:25]([N:16]2[C:17]3[C:12](=[CH:11][C:10]([CH2:9][OH:8])=[C:19]([CH:20]=[O:23])[N:18]=3)[CH2:13][CH2:14][CH2:15]2)=[O:27])=[N:36][CH:37]=1)#[N:40]

Participants

6

Conditions

Temperature
-78 °C

Procedure

Phenyl 6-(((tert-butyldimethylsilyl)oxy)methyl)-7-(dimethoxymethyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxylate (intermediate 38, 40 mg, 0.085 mmol) and 6-amino-4-((tetrahydro-2H-pyran-4-yl)oxy)nicotinonitrile (intermediate 45B, 22.3 mg, 0.102 mmol) were dissolved in THF (1 ml) under argon. The resulting solution was cooled to −78° C. and treated slowly with LHMDS (1 M in THF, 0.186 ml, 0.186 mmol). The reaction mixture was stirred at −78° C. for 45 min and then slowly warmed up to room temperature. The reaction mixture was poured into NH4Cl sat. aq. and extracted twice with DCM. The organic phase was then dried over Na2SO4, filtered and evaporated. The crude material was purified by preparative supercritical fluid chromatography (SFC 1, NH2 column). The 6-(((tert-butyldimethylsilyl)oxy)methyl)-N-(5-cyano-4-((tetrahydro-2H-pyran-4-yl)oxy)pyridin-2-yl)-7-(dimethoxymethyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide containing fractions were concentrated and then dissolved in THF (1 ml) and water (1 ml) and treated with conc. HCl (0.14 ml). The reaction mixture was stirred 16 h at room temperature. The reaction mixture was quenched with sat. aq. NaHCO3 and extracted with DCM (3×). The org layer was dried over Na2SO4, filtered and concentrated under vacuum. The crude material was treated with a small quantity of DCM and then the product was precipitated by addition of heptane. The solid was collected by centrifugation and dried under vacuum to obtain the title compound as a white solid.

Workup

  1. temperatureslowly warmed up to room temperature
  2. extractionextracted twice with DCM
  3. dry with materialThe organic phase was then dried over Na2SO4
  4. filtrationfiltered
  5. customevaporated
  6. customThe crude material was purified by preparative supercritical fluid chromatography (SFC 1, NH2 column)
  7. concentrationThe 6-(((tert-butyldimethylsilyl)oxy)methyl)-N-(5-cyano-4-((tetrahydro-2H-pyran-4-yl)oxy)pyridin-2-yl)-7-(dimethoxymethyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide containing fractions were concentrated
  8. dissolutiondissolved in THF (1 ml)
  9. additionwater (1 ml) and treated with conc. HCl (0.14 ml)
  10. stirringThe reaction mixture was stirred 16 h at room temperature
  11. customThe reaction mixture was quenched with sat. aq. NaHCO3
  12. extractionextracted with DCM (3×)
  13. dry with materialThe org layer was dried over Na2SO4
  14. filtrationfiltered
  15. concentrationconcentrated under vacuum
  16. additionThe crude material was treated with a small quantity of DCM
  17. customthe product was precipitated by addition of heptane
  18. customThe solid was collected by centrifugation
  19. customdried under vacuum

Sources & evidence

ORD record
ord-8d3842c526fe47f6a203dc98b58a446d
Source dataset
uspto-grants-2016_02
Patent number
US09266883B2

Reaction notes

Loading…